Patent · US Active

In vitro differentiation of pluripotent stem cells to pancreatic endoderm cells (PEC) and endocrine cells

US8859286B2 · kind B2 · utility

80Cited by
21References
20Claims
0Family size

Assignee

Inventor

Key dates

Filing dateDec 13, 2013
Grant dateOct 14, 2014
Priority date
Expiry dateDec 13, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2533/90
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A human immature endocrine cell population and methods for making an immature endocrine cell population are provided. Specifically, immature beta cells and methods for production of immature beta cells are described. Immature beta cells co-express INS and NKX6.1 and are uni-potent and thereby develop into mature beta cells when implanted in vivo. The mature beta cells in vivo are capable of producing insulin in response to glucose stimulation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.